Vasopressin

Arginine Vasopressin (AVP)

Evidence & Status

  • FDA Approved
  • Strong Human Evidence
  • Strong

At a Glance

Native arginine vasopressin with VASOSTRICT label-scoped U.S. use.

Plain English

This record limits product information to the VASOSTRICT labeled intravenous adult vasodilatory-shock scope.

Overview

Native arginine vasopressin is a nonapeptide. This record is limited to current VASOSTRICT label scope: intravenous use in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Research Summary

Route, preparation, dosing, warnings, safety, and storage are label-specific. This record does not include generic diabetes-insipidus approval, intranasal, cognitive, desmopressin, WADA, or universal half-life claims.

Research Areas

  • Memory consolidation
  • Social cognition and behavior
  • Stress response
  • Central diabetes insipidus
  • Vasodilatory/septic shock
  • Emotional processing
United States
VASOSTRICT is labeled for intravenous use in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.
United Kingdom
MHRA-approved prescription drug
Australia
TGA-approved prescription drug
Canada
Health Canada-approved

Citations & Sources